{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:46:32Z","timestamp":1759693592169},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Dutch Organisation for Health Research and Development","award":["916.76.048"],"award-info":[{"award-number":["916.76.048"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research: Neuroimaging"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.pscychresns.2017.11.014","type":"journal-article","created":{"date-parts":[[2017,11,21]],"date-time":"2017-11-21T23:02:12Z","timestamp":1511305332000},"page":"65-70","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Dopamine in high-risk populations: A comparison of subjects with 22q11.2 deletion syndrome and subjects at ultra high-risk for psychosis"],"prefix":"10.1016","volume":"272","author":[{"given":"Claudia","family":"Vingerhoets","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oswald J.N.","family":"Bloemen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik","family":"Boot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geor","family":"Bakker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariken B.","family":"de Koning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiana","family":"da Silva Alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Booij","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Th\u00e9r\u00e8se A.M.J.","family":"van Amelsvoort","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pscychresns.2017.11.014_bib1","doi-asserted-by":"crossref","first-page":"8104","DOI":"10.1073\/pnas.97.14.8104","article-title":"Increased baseline occupancy of D2 receptors by dopamine in schizophrenia","volume":"97","author":"Abi-Dargham","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.pscychresns.2017.11.014_bib2","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.biopsych.2008.12.007","article-title":"Baseline and amphetamine-stimulated dopamine activity are related in drug-na\u00efve schizophrenic subjects","volume":"65","author":"Abi-Dargham","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pscychresns.2017.11.014_bib3","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.schres.2012.04.020","article-title":"Adolescents at ultra-high risk for psychosis with and without 22q11 deletion syndrome: a comparison of prodromal psychotic symptoms and general functioning","volume":"139","author":"Armando","year":"2012","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pscychresns.2017.11.014_bib4","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/oxfordjournals.schbul.a006884","article-title":"Genetic insights into the neurodevelopmental hypothesis of schizophrenia","volume":"27","author":"Basset","year":"2001","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.pscychresns.2017.11.014_bib5","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1176\/appi.ajp.160.9.1580","article-title":"The schizophrenia phenotype in 22q11 deletion syndrome","volume":"160","author":"Bassett","year":"2003","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pscychresns.2017.11.014_bib6","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1038\/sj.npp.1300542","article-title":"The catechol-O-methyltransferase polymorphism: relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes","volume":"29","author":"Bilder","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pscychresns.2017.11.014_bib7","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.euroneuro.2012.04.015","article-title":"Striatal dopamine D2\/3 receptor binding following dopamine depletion in subjects at Ultra High Risk for psychosis","volume":"23","author":"Bloemen","year":"2013","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.pscychresns.2017.11.014_bib8","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/jnnp.62.2.133","article-title":"[123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease","volume":"62","author":"Booij","year":"1997","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.pscychresns.2017.11.014_bib9","series-title":"Imaging as Tool to Investigate Psychoses and Antipsychotics, Handbook of Experimental Pharmacology","author":"Booij","year":"2012"},{"key":"10.1016\/j.pscychresns.2017.11.014_bib10","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1038\/sj.npp.1301508","article-title":"Disrupted dopaminergic neurotransmission in 22q11 deletion syndrome","volume":"33","author":"Boot","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pscychresns.2017.11.014_bib11","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1002\/syn.20932","article-title":"COMT Val(158) met genotype and striatal D(2\/3) receptor binding in adults with 22q11 deletion syndrome","volume":"65","author":"Boot","year":"2011","journal-title":"Synapse"},{"key":"10.1016\/j.pscychresns.2017.11.014_bib12","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1177\/0269881109104854","article-title":"Striatal D2 receptor binding in 22q11 deletion syndrome: an [123I]IBZM SPECT study","volume":"24","author":"Boot","year":"2010","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pscychresns.2017.11.014_bib13","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.2174\/156802612805289854","article-title":"Neuroimaging correlates of 22q11.2 deletion syndrome: implications for schizophrenia research","volume":"12","author":"Boot","year":"2012","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.pscychresns.2017.11.014_bib14","doi-asserted-by":"crossref","first-page":"14273","DOI":"10.1523\/JNEUROSCI.1894-10.2010","article-title":"Influence of phasic and tonic dopamine release on receptor activation","volume":"30","author":"Dreyer","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pscychresns.2017.11.014_bib15","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.biopsych.2012.11.017","article-title":"Presynaptic striatal dopamine dysfunction in people at ultra-high risk for psychosis: findings in a second cohort","volume":"74","author":"Egerton","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pscychresns.2017.11.014_bib16","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1017\/S1461145714000376","article-title":"Serotonergic, noradrenergic and dopaminergic markers are related to cognitive function in adults with 22q11 deletion syndrome","volume":"17","author":"Evers","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.pscychresns.2017.11.014_bib17","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1017\/S1461145706006985","article-title":"22q11.2 deletion syndrome as a natural model for COMT haploinsufficiency-related dopaminergic dysfunction in ADHD","volume":"10","author":"Fallgatter","year":"2007","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.pscychresns.2017.11.014_bib18","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.eurpsy.2011.06.006","article-title":"Mapping prodromal psychosis: a critical review of neuroimaging studies","volume":"27","author":"Fusar-Poli","year":"2012","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.pscychresns.2017.11.014_bib19","doi-asserted-by":"crossref","first-page":"9991","DOI":"10.1073\/pnas.95.17.9991","article-title":"Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior","volume":"95","author":"Gogos","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.pscychresns.2017.11.014_bib20","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1038\/nn1572","article-title":"COMT genotype predicts longitudinal cognitive decline and psychosis in 22q11.2 deletion syndrome","volume":"8","author":"Gothelf","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.pscychresns.2017.11.014_bib21","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.biopsych.2013.07.021","article-title":"Biological effects of COMT haplotypes and psychosis risk in 22q11.2 deletion syndrome","volume":"75","author":"Gothelf","year":"2014","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pscychresns.2017.11.014_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0306-4522(91)90196-U","article-title":"Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia","volume":"41","author":"Grace","year":"1991","journal-title":"Neuroscience"},{"key":"10.1016\/j.pscychresns.2017.11.014_bib23","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1212\/WNL.57.3.410","article-title":"Catecholamines in patients with 22q11.2 deletion syndrome and the low-activity COMT polymorphism","volume":"57","author":"Graf","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.pscychresns.2017.11.014_bib24","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.2165\/00003495-200464200-00003","article-title":"Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management","volume":"64","author":"Haddad","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.pscychresns.2017.11.014_bib25","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/mp.2011.20","article-title":"Progressive increase in striatal dopamine synthesis capacity as patients develop psychosis: a PET study","volume":"16","author":"Howes","year":"2011","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pscychresns.2017.11.014_bib26","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1001\/archgenpsychiatry.2012.169","article-title":"The nature of dopamine dysfunction in schizophrenia and what this means for treatment","volume":"69","author":"Howes","year":"2012","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pscychresns.2017.11.014_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1192\/bjp.bp.113.138578","article-title":"A neurobiological hypothesis for the classification of schizophrenia: type A (hyperdopaminergic) and type B (normodopaminergic)","volume":"205","author":"Howes","year":"2014","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.pscychresns.2017.11.014_bib28","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/schbul\/sbp006","article-title":"The dopamine hypothesis of schizophrenia: version III--the final common pathway","volume":"35","author":"Howes","year":"2009","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.pscychresns.2017.11.014_bib29","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1001\/archgenpsychiatry.2008.514","article-title":"Elevated striatal dopamine function linked to prodromal signs of schizophrenia","volume":"66","author":"Howes","year":"2009","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pscychresns.2017.11.014_bib30","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0140-6736(13)62036-X","article-title":"Schizophrenia: an integrated sociodevelopmental-cognitive model","volume":"383","author":"Howes","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.pscychresns.2017.11.014_bib31","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1046\/j.0953-816x.2001.01856.x","article-title":"Brain catecholamine metabolism in catechol-O-methyltransferase (COMT)-deficient mice","volume":"15","author":"Huotari","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pscychresns.2017.11.014_bib32","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.biopsych.2013.07.019","article-title":"The 22q11.2 deletion syndrome as a window into complex neuropsychiatric disorders over the lifespan","volume":"75","author":"Jonas","year":"2014","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pscychresns.2017.11.014_bib33","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1176\/appi.ajp.160.1.13","article-title":"Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia","volume":"160","author":"Kapur","year":"2003","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pscychresns.2017.11.014_bib34","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The Positive and Negative Syndrome Scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.pscychresns.2017.11.014_bib35","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1001\/archgenpsychiatry.2010.10","article-title":"Increased synaptic dopamine function in associative regions of the striatum in schizophrenia","volume":"67","author":"Kegeles","year":"2010","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pscychresns.2017.11.014_bib36","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/00004647-200003000-00001","article-title":"Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review","volume":"20","author":"Laruelle","year":"2000","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.pscychresns.2017.11.014_bib37","doi-asserted-by":"crossref","first-page":"9235","DOI":"10.1073\/pnas.93.17.9235","article-title":"Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects","volume":"93","author":"Laruelle","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.pscychresns.2017.11.014_bib38","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF02260898","article-title":"Behavioural and neurochemical effects of Ro 40-7592, a new COMT inhibitor with a potential therapeutic activity in Parkinson's disease","volume":"2","author":"Maj","year":"1990","journal-title":"J. Neural Transm. Park. Dis. Dement. Sect."},{"key":"10.1016\/j.pscychresns.2017.11.014_bib39","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1192\/bjp.179.5.397","article-title":"Velo-cardio-facial syndrome: a model for understanding the genetics and pathogenesis of schizophrenia","volume":"179","author":"Murphy","year":"2001","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.pscychresns.2017.11.014_bib40","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1001\/archpsyc.56.10.940","article-title":"High rates of schizophrenia in adults with Velo-Cardio-Facial Syndrome","volume":"56","author":"Murphy","year":"1999","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pscychresns.2017.11.014_bib41","doi-asserted-by":"crossref","first-page":"e31305","DOI":"10.1371\/journal.pone.0031305","article-title":"Prolactin secretion in healthy adults is determined by gender, age and body mass index","volume":"7","author":"Roelfsema","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pscychresns.2017.11.014_bib42","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1093\/schbul\/sbs147","article-title":"Neural and behavioral correlates of aberrant salience in individuals at risk for psychosis","volume":"39","author":"Roiser","year":"2013","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.pscychresns.2017.11.014_bib43","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.mri.2007.06.007","article-title":"Regional variations and the effects of age and gender on glutamate concentrations in the human brain","volume":"26","author":"Sailasuta","year":"2008","journal-title":"Magn. Reson. Imaging"},{"key":"10.1016\/j.pscychresns.2017.11.014_bib44","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1176\/appi.ajp.2013.13070864","article-title":"Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome: results from the International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome","volume":"171","author":"Schneider","year":"2014","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pscychresns.2017.11.014_bib45","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1177\/0269881106073126","article-title":"Glutamate and dopamine dysregulation in schizophrenia--a synthesis and selective review","volume":"21","author":"Stone","year":"2007","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pscychresns.2017.11.014_bib46","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.biopsych.2005.10.024","article-title":"Catechol-o-methyltransferase, cognition, and psychosis: Val158Met and beyond","volume":"60","author":"Tunbridge","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pscychresns.2017.11.014_bib47","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nature09563","article-title":"The environment and schizophrenia","volume":"468","author":"van Os","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.pscychresns.2017.11.014_bib48","doi-asserted-by":"crossref","first-page":"10196","DOI":"10.1523\/JNEUROSCI.0665-07.2007","article-title":"Site-specific role of catechol-O-methyltransferase in dopamine overflow within prefrontal cortex and dorsal striatum","volume":"27","author":"Yavich","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pscychresns.2017.11.014_bib49","doi-asserted-by":"crossref","first-page":"s1","DOI":"10.1192\/bjp.191.51.s1","article-title":"Prediction of psychosis: setting the stage","volume":"51","author":"Yung","year":"2007","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.pscychresns.2017.11.014_bib50","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0920-9964(03)00192-0","article-title":"Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features","volume":"67","author":"Yung","year":"2004","journal-title":"Schizophr. Res."}],"container-title":["Psychiatry Research: Neuroimaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925492717301920?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925492717301920?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T11:08:56Z","timestamp":1560337736000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925492717301920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":50,"alternative-id":["S0925492717301920"],"URL":"https:\/\/doi.org\/10.1016\/j.pscychresns.2017.11.014","relation":{},"ISSN":["0925-4927"],"issn-type":[{"value":"0925-4927","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dopamine in high-risk populations: A comparison of subjects with 22q11.2 deletion syndrome and subjects at ultra high-risk for psychosis","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research: Neuroimaging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pscychresns.2017.11.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}